Citation Impact
Citing Papers
Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response
2013 StandoutNobel
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring
2016 StandoutScience
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
2019 StandoutScienceNobel
Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
2005 StandoutNobel
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein
2002 StandoutScience
CD4+ Tregs and immune control
2004 StandoutNobel
Pathologic heterogeneity persists in early active multiple sclerosis lesions
2014
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Presentation of the Self Antigen Myelin Basic Protein by Dendritic Cells Leads to Experimental Autoimmune Encephalomyelitis
1999
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
2014
Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
2019 StandoutNobel
Re-establishing immunological self-tolerance in autoimmune disease
2012 StandoutNobel
Induction of regulatory Tr1 cells and inhibition of TH17 cells by IL-27
2011
Design of effective immunotherapy for human autoimmunity
2005 Nature
A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies
2003 Standout
Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis
2003
Encephalitogenic and immunogenic potential of myelin-associated glycoprotein (MAG), oligodendrocyte-specific glycoprotein (OSP) and 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in ABH and SJL mice
2002
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases
2009
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
2010 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Systemic manifestations and comorbidities of COPD
2009
Isolation and characteristics of autoreactive T cells specific to aggrecan G1 domain from rheumatoid arthritis patients
2000
National Institutes of Health Center for Human Immunology Conference, September 2009
2010
A new approach for evaluating antigen-specific T cell responses to myelin antigens during the course of multiple sclerosis
2003
Natural killer cell–directed therapies: moving from unexpected results to successful strategies
2008
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
2014 StandoutNobel
Regulatory T Cells
2010
A PD‐1 polymorphism is associated with disease progression in multiple sclerosis
2005
Role of costimulatory pathways in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis
2003
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
1995
HLA-DR2–restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice
2000
Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells
2000
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
TCR repertoire to proteolipid protein (PLP) in multiple sclerosis (MS): homologies between PLP-specific T cells and MS-associated T cells in TCR junctional sequences
1996
Autoimmune T cell responses in the central nervous system
2009
Multiple sclerosis candidate autoantigens except myelin oligodendrocyte glycoprotein are transcribed in human thymus
2002
Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis
1997
Interleukin-2 Activity Can Be Fine Tuned with Engineered Receptor Signaling Clamps
2015
Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.
1998
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regions
1997
Multiple sclerosis
2008 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
The same TCR (N)Dβ(N)Jβ junctional region is associated with several different vβ13 subtypes in a multiple sclerosis patient at the onset of the disease
2003
Treatment of multiple sclerosis with T–cell receptor peptides: Results of a double–blind pilot trial
1996
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
2006
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
2009 StandoutNobel
Indirect recognition of donor HLA-DR peptides in organ allograft rejection.
1996
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research
2006
Molecular and cellular mechanisms of liver fibrosis and its regression
2020
Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis
2017
Graves' Ophthalmopathy
2010 Standout
Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.
1996
Specificity of autoantibodies to epitopes of myelin proteins in multiple sclerosis
2002
CTLA-4 dysregulation in the activation of myelin basic protein reactive T cells may distinguish patients with multiple sclerosis from healthy controls
2003
SLAM Family Receptors Distinguish Hematopoietic Stem and Progenitor Cells and Reveal Endothelial Niches for Stem Cells
2005 Standout
Cross‐reactivity with myelin basic protein and human herpesvirus‐6 in multiple sclerosis
2003
Recognition of Conserved Amino Acid Motifs of Common Viruses and Its Role in Autoimmunity
2005 StandoutNobel
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
2000
Adaptive immunity and atherosclerosis
2009
Identification of an epitope derived from human proteolipid protein that can induce autoreactive CD8+ cytotoxic T lymphocytes restricted by HLA-A3: evidence for cross-reactivity with an environmental microorganism
1997
Bothanti-CD11a(LFA-l) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis
1995
Ex vivo detection of myelin basic protein‐reactive T cells in multiple sclerosis and controls using specific TCR oligonucleotide probes
2004
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
T cell vaccination in multiple sclerosis: results of a preliminary study
2002
Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis.
1997
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Pleiotropic effects of statin therapy: molecular mechanisms and clinical results
2008
FOXP3+ regulatory T cells in the human immune system
2010 StandoutNobel
HPRT mutant T-cell lines from multiple sclerosis patients recognize myelin proteolipid protein peptides
1997
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
2002 StandoutNature
Blood transcriptional signatures of multiple sclerosis: Unique gene expression of disease activity
2004
The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration
2006
Myeloid cells — targets of medication in multiple sclerosis
2016
TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis
2003
HLA-DP: A Class II Restriction Molecule Involved in Epitope Spreading During the Development of Multiple Sclerosis
1998
Chemokine receptor expression on MBP-reactive T cells: CXCR6 is a marker of IFNγ-producing effector cells
2002
Deciphering the role of Th17 cells in human disease
2011
Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells
2014
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
1997 StandoutNature
Mevalonate pathway: A review of clinical and therapeutical implications
2007
FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS
2014
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
2014 Standout
Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein
1995
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
CD8+ Myelin Peptide-Specific T Cells Can Chemoattract CD4+ Myelin Peptide-Specific T Cells: Importance of IFN-Inducible Protein 10
1998
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Computational design of a synthetic PD-1 agonist
2021 StandoutNobel
Expansion of Autoreactive T Cells in Multiple Sclerosis Is Independent of Exogenous B7 Costimulation
1998
T cells from multiple sclerosis patients recognize immunoglobulin G from cerebrospinal fluid
2003
Efficient Presentation of Phagocytosed Cellular Fragments on the Major Histocompatibility Complex Class II Products of Dendritic Cells
1998 StandoutNobel
T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission
1998
Rationally Engineered Therapeutic Proteins with Reduced Immunogenicity
2005
Interactions Between the Microbiota and the Immune System
2012 StandoutScience
IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential
2012
Multiple Sclerosis
2018 Standout
Type I Diabetes and Multiple Sclerosis Patients Target Islet Plus Central Nervous System Autoantigens; Nonimmunized Nonobese Diabetic Mice Can Develop Autoimmune Encephalitis
2001
Role for IL-10 in Suppression Mediated by Peptide-Induced Regulatory T Cells In Vivo
2003
High Frequency of Autoreactive Myelin Proteolipid Protein–Specific T Cells in the Periphery of Naive Mice
2000
CD49d provides access to “untouched” human Foxp3+ Treg free of contaminating effector cells
2008
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
2012 StandoutNobel
Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction
2000
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
CD4+ Tregs and immune control
2004 StandoutNobel
Fluorescent Sensors for Measuring Metal Ions in Living Systems
2014 Standout
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients
2012
Myelin-Associated Oligodendrocytic Basic Protein: Identification of an Encephalitogenic Epitope and Association with Multiple Sclerosis
2000
Increased CD8+ Cytotoxic T Cell Responses to Myelin Basic Protein in Multiple Sclerosis
2004
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions.
1995
Expansion and Functional Relevance of High-Avidity Myelin-Specific CD4+ T Cells in Multiple Sclerosis
2004
Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans
2011
Cell-intrinsic role for IFN-α–STAT1 signals in regulating murine Peyer patch plasmacytoid dendritic cells and conditioning an inflammatory response
2011
High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay
2004
Oral tolerance.
1994
The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon γ production
2002
TSLP: An Epithelial Cell Cytokine that Regulates T Cell Differentiation by Conditioning Dendritic Cell Maturation
2006
IL-23 and Autoimmunity: New Insights into the Pathogenesis of Inflammatory Bowel Disease
2008
Specific Proliferation Towards Myelin Antigens in Patients with Multiple Sclerosis During a Relapse
2002
Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy
2015
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
The Human T Cell Response to Myelin Oligodendrocyte Glycoprotein: A Multiple Sclerosis Family-Based Study
2002
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Direct Ex Vivo Analysis of Activated, Fas-sensitive Autoreactive T Cells in Human Autoimmune Disease
1997
Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion
2016 StandoutNobel
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
2004
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
2014 StandoutNobel
Works of Silva Markovic‐Plese being referenced
Simvastatin inhibits secretion of T h17‐polarizing cytokines and antigen presentation by DC s in patients with relapsing remitting multiple sclerosis
2012
Simvastatin Inhibits IL-17 Secretion by Targeting Multiple IL-17-Regulatory Cytokines and by Inhibiting the Expression of IL-17 Transcription Factor RORC in CD4+ Lymphocytes
2008
IFN-β Inhibits Human Th17 Cell Differentiation
2009
IFN-β1a Inhibits the Secretion of Th17-Polarizing Cytokines in Human Dendritic Cells via TLR7 Up-Regulation
2009
Molecular Mimicry and Antigen-Specific T Cell Responses in Multiple Sclerosis and Chronic CNS Lyme Disease
2001
CD4+CD28– costimulation-independent T cells in multiple sclerosis
2001
Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate
2012
High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+ T-cell response: Implications for the initiation of autoimmune response in multiple sclerosis
2005
Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis
2006
Degenerate TCR recognition and dual DR2 restriction of autoreactive T cells: Implications for the initiation of the autoimmune response in multiple sclerosis
2008
Oral simvastatin treatment in relapsing-remitting multiple sclerosis
2004
Dendritic cells signal T cells in the absence of exogenous antigen
2001
B Cells as a Therapeutic Target for IFN-β in Relapsing–Remitting Multiple Sclerosis
2011
Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
1994
Interferon-beta Inhibits Th17 Cell Differentiation in Patients with Multiple Sclerosis
2010
CD4+CD28– costimulation-independent T cells in multiple sclerosis
2001
Combinatorial Peptide Libraries and Biometric Score Matrices Permit the Quantitative Analysis of Specific and Degenerate Interactions Between Clonotypic TCR and MHC Peptide Ligands
2001
T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans
1995
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β
2004